Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for Helicobacter pylori: a territory-wide cohort study.

Chuan-Guo GuoKa Shing CheungFeifei ZhangEsther W ChanLijia ChenIan Ck WongWai-Keung Leung

Published in: Gut (2019)

New aspirin users had a higher risk of GIB than chronic aspirin users, particularly during the initial 6 months. Lower GIB is more frequent than upper GIB in aspirin users who had HP eradicated.

Keyphrases

low dose
helicobacter pylori
high dose
cardiovascular events
antiplatelet therapy
helicobacter pylori infection
anti inflammatory drugs
acute coronary syndrome
coronary artery disease
climate change
atrial fibrillation
percutaneous coronary intervention